166 related articles for article (PubMed ID: 7961122)
1. Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung.
Nakagawa H; Yagihashi S
Jpn J Cancer Res; 1994 Sep; 85(9):934-8. PubMed ID: 7961122
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma.
Charous SJ; Stricklin GP; Nanney LB; Netterville JL; Burkey BB
Ann Otol Rhinol Laryngol; 1997 Apr; 106(4):271-8. PubMed ID: 9109715
[TBL] [Abstract][Full Text] [Related]
3. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
4. Regulation of collagen degradation in the rat myocardium after infarction.
Cleutjens JP; Kandala JC; Guarda E; Guntaka RV; Weber KT
J Mol Cell Cardiol; 1995 Jun; 27(6):1281-92. PubMed ID: 8531210
[TBL] [Abstract][Full Text] [Related]
5. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.
Zeng ZS; Cohen AM; Guillem JG
Carcinogenesis; 1999 May; 20(5):749-55. PubMed ID: 10334190
[TBL] [Abstract][Full Text] [Related]
6. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
[TBL] [Abstract][Full Text] [Related]
7. Expression and activity of MMPS and their regulators in ovarian cancer.
Naylor MS; Stamp GW; Davies BD; Balkwill FR
Int J Cancer; 1994 Jul; 58(1):50-6. PubMed ID: 8014015
[TBL] [Abstract][Full Text] [Related]
8. [Matrix metalloproteinase-2 concentrations in squamous cell carcinoma of the head and neck and its clinical significance].
Kawata R; Shinomiya T; Yasuda N; Takenaka H; Murakami Y
Nihon Jibiinkoka Gakkai Kaiho; 1996 Feb; 99(2):299-305. PubMed ID: 8851335
[TBL] [Abstract][Full Text] [Related]
9. Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinase messenger RNAs in human breast cancer.
Lindsay CK; Thorgeirsson UP; Tsuda H; Hirohashi S
Hum Pathol; 1997 Mar; 28(3):359-66. PubMed ID: 9042802
[TBL] [Abstract][Full Text] [Related]
10. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
11. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
12. Expression of MMP-1, TIMP-1, and type I collagen in laryngeal carcinoma.
Sawatsubashi M; Mizokami H; Tokunaga O; Shin T
Mod Pathol; 1998 Sep; 11(9):878-85. PubMed ID: 9758368
[TBL] [Abstract][Full Text] [Related]
13. Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas.
Lindsay CK; Thorgeirsson UP
Clin Exp Metastasis; 1995 Sep; 13(5):381-8. PubMed ID: 7641422
[TBL] [Abstract][Full Text] [Related]
14. 72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells.
González-Avila G; Iturria C; Vadillo F; Terán L; Selman M; Pérez-Tamayo R
Pathobiology; 1998; 66(1):5-16. PubMed ID: 9577961
[TBL] [Abstract][Full Text] [Related]
15. Inter-regulated balance between gelatinases and tissue inhibitor (TIMP-1) in isolated human glomeruli.
Zaoui P; Barro C; Maynard C; Descotes JL; Maurizi-Balzan J; Cordonnier DJ; Morel F
Ren Fail; 1998 Mar; 20(2):201-9. PubMed ID: 9574444
[TBL] [Abstract][Full Text] [Related]
16. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas.
Johansson N; Vaalamo M; Grénman S; Hietanen S; Klemi P; Saarialho-Kere U; Kähäri VM
Am J Pathol; 1999 Feb; 154(2):469-80. PubMed ID: 10027405
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex.
Sava G; Capozzi I; Bergamo A; Gagliardi R; Cocchietto M; Masiero L; Onisto M; Alessio E; Mestroni G; Garbisa S
Int J Cancer; 1996 Sep; 68(1):60-6. PubMed ID: 8895542
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Iizasa T; Fujisawa T; Suzuki M; Motohashi S; Yasufuku K; Yasukawa T; Baba M; Shiba M
Clin Cancer Res; 1999 Jan; 5(1):149-53. PubMed ID: 9918213
[TBL] [Abstract][Full Text] [Related]
19. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
20. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]